In this episode of the Association of Cannabinoids Specialists, host John Malanca is joined by Dr. Jordan Tishler and Dr. Suraj Tandon to discuss the topic of CBD.
Dr. Tishler advocates for more human data and cautions about the limitations of current research, particularly noting CBD's proven efficacy in treating epilepsy in children but not definitively for other adult conditions like anxiety, pain, and insomnia. Dr. Tishler also highlights issues with high dosage requirements, potential drug interactions, and costs affecting its practical use.
Dr. Tandon shares the Canadian perspective on cannabis legalization, the benefits and drawbacks of CBD, and the importance of regulation and quality control in medical cannabis. Both doctors emphasize the necessity of consulting healthcare professionals before starting any cannabinoid treatment and advise on the importance of provider education in developing informed recommendations.